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1. Introduction
  Type 2 diabetes mellitus is one of the world’s most 
common chronic metabolic disorders of multiple aetiologies 
and it is projected to increase to 438 million in 2030[1]. The 
early phenomenon of type 2 diabetes mellitus is insulin 
insensitivity, which not only has negative metabolic 
consequences but also contributes subsequent pancreas 
毬-cell exhaustion, resulting in the onset of clinical 
hyperglycemia[2]. Thus, understanding the regulation of the 
insulin response and identifying the related mechanisms 
are important to early treatment and prevention of type 2 
diabetes mellitus.
  Lifestyle modifications are often recommended, but have 
been difficult to maintain over a long term. Benefits of 
pharmaceutical factors to treat the disease aggressively 
early have been recommended, but medications may have 
unwanted side effects. Thus, there has been a growing 
interest in herbal remedies that can be introduced into 
the general population with the least side effects and the 
maximal preventive outcome.   
  Semecarpus anacardium (S. anacardium) commonly 
known as bhallataka has been used in various pathologies 
in Indian systems of medicine found in outer Himalayas 
and hotter parts of central India[3]. Jeediflavanone, 
galluflavanone, nalluflavanone, semecarpetin, and 
anacardiflavanone have been identified as chief 
constituents in the drug[4]. HPLC and HPTLC analysis of the 
nut and milk extract were also carried out to confirm the 
presence of the above said compounds[5]. The drug is known 
to have anti diabetic and anti inflammatory property[6]. In 
experimental diabetes, enzymes of glucose metabolism are 
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markedly altered and produce hyperglycemia, which leads 
to pathogenesis of diabetic complications. The present study 
was carried out test the efficacy of the drug S. anacardium 
in modulating the metabolic anomalies associated with type 
2 diabetes mellitus through insulin signalling molecule.
2. Materials and methods
2.1. Animals and diet
  Male Sprague dawley rats [(230依20) g] were used in this 
study. The animals were purchased from Central Animal 
House, Institute of Basic Medical Sciences, Chennai, 
India. Animal experimentation was conducted according 
to the current CPCSEA regulations (IAEC no. 02/081/07). 
The animals were maintained on a commercial rat feed 
manufactured by M/s. Pranav Agro Industries Ltd., India 
under the trade name “Amrut rat/mice feed”.
2.2. Preparation of the drug 
  S. anacardium Linn. nut extract contains purified nuts 
of S. anacardium and cow’s milk in the ratio as indicated 
in the Formulary of Siddha Medicine. 200 g of the nut was 
boiled with 500 mL of milk, which was repeated thrice. The 
decoction was stored at room temperature[7] and this was 
used for the study. 
2.3. Drugs
  Streptozotocin (STZ) was obtained from Sigma Chemicals, 
St. Louis, Mo., U.S.A. All other chemicals and solvents used 
were of analytical grade.
2.4. Induction of experimental diabetes 
  Diabetes was induced in rats by feeding them with a 
high fat diet consisting of 10% lard, 20% sucrose, 2.5% 
cholesterol, 1.0% cholate for 2 weeks[8]. After 2 weeks the 
animals were kept in an overnight fast and injected with 
STZ (35 mg/kg body weight in 0.1 M citrate buffer pH-4.5)[9].
Animals had free access to food and water after the STZ 
injection. Rats with blood glucose level ≥126 mg /dL at 
0 min or ≥199.8 mg/dL at 120 min were considered to be 
diabetic and used for the study.  Both STZ injected and non-
injected animals continued on their original diet throughout 
the study. The authors declare that the experiments 
conducted during these studies comply with the current laws 
of their country.
2.5. Experimental design
  The animals were randomly divided into five groups of six 
animals each. Group 栺 served as a control receiving olive 
oil as vehicle. Group 栻 diabetic rats served as diabetic 
control rats. Group 栿 diabetic rats were treated with S. 
anacardium at a dosage of 200 mg/kg.b.wt for four weeks, 
Group 桇 diabetic rats were treated with the standard drug 
metformin at a dosage of 500 mg/kg.b.wt for four weeks[10], 
Group 桋 control rats were given S. anacardium alone at 
different dosage of 200 mg/kg.b.wt for four weeks and they 
served as drug control group.  
2.6. Biochemical analysis
  After 30 days of treatment, the animals were sacrificed 
under chloroform anesthesia. The blood was collected and 
serum was separated and used for biochemical estimations. 
Liver and skeletal muscle tissues were quickly excised off, 
a portion of liver and skeletal muscle tissues were washed 
with saline and their homogenates were prepared using 
0.1 M phosphate buffer, pH 7.4. The homogenates were 
centrifuged and the supernatant was used for the study. The 
levels of blood glucose were done according to Trinder[11], 
HOMA-IR and HOMA-毬 by the method of Mathews et 
al[12]. Insulin was assayed by the solid phase enzyme linked 
immunosorbent assay.
  Hexokinase was assayed by the method of Banstrup et 
al[13]. Phosphogluco-isomerase was assayed by the method 
of Horrocks et al[14]. Aldolase was estimated by the method 
of King[15]. Glucose-6-phosphatase was assayed according 
to the method of Gancedo and Gancedo[16]. Fructose1, 
6-biphosphatase was assayed by the method of Gancedo 
and Gancedo[16].Glucose 6 phosphate dehydrogenase 
activity was assayed by the method of Beutler[17]. Glycogen 
phosphorylase activity was determined by the method of 
Shull et al[18]. Glycogen content in liver and muscle was 
estimated by the method of Morales et al[19]. 
2.7. Total RNA Isolation and RT-PCR
  Total RNA was purified from freshly liver tissue using 
1 mL of the TRI reagent by the method of Chomczynski 
and Sacchi[20]. The RNA purity and concentration were 
determined spectrophotometrically at A260/A280 nm. The 
purity of RNA obtained was 1.8-1.9. 1 g of total RNA were 
reverse transcribed by RT-PCR kit (INVITROGEN) according 
to the manufacturer’s instructions and further amplified by 
PCR. 
G S K - 3 - T G G T C C G A G G A G A G C C C A A T G T /
TGCCTCTGGTGGAGTTCGGGG-35/55 曟-320-NM032080.1
G A P D H -  G C T C T C T G C T C C T C C C T G T T C T A G A / 
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A C A A A C A T G G G G G C A T C A G C G G - 3 5 / 5 5  曟- 4 6 1 - 
NM_017008.3. 
  The PCR products were resolved by electrophoresis through 
a 2% agarose gel and stained with ethidium bromide. 
The densities of PCR products in the agarose gel were 
scanned with a Gel Doc image scanner (Bio-Rad, USA), and 
quantified by Quantity One Software (Bio-Rad, USA).
2.8. Statistical analysis
  All the values were expressed as mean依SD of 6 rats from 
each group and statistically evaluated by one way analysis 
of variance followed by Duncan’s Multiple Range Test for 
multiple comparisons. A value of P<0.05 was considered 
statistically significant.
3. Results
3.1. Effect of S. anacardium Linn. nut milk extract on blood 
glucose, insulin, HOMA -IR and HOMA 毬
  Table 1 depicts the levels of blood glucose, plasma 
insulin, HOMA-IR and HOMA 毬 of control and experimental 
groups of rats. The diabetic rats showed a significant (P<0.05) 
increase in the levels of glucose and alterations in HOMA -IR
and HOMA 毬. S. anacardium treatment resulted in decrease 
in the blood glucose level when compared to diabetic 
rats. No changes were compared with drug alone treated 
groups. No significant alterations were observed in insulin 
level between the diabetic rats when compared to control 
rats. And also S. anacardium treatment resulted in the 
improvement in the aberrations in HOMA-IR and HOMA-毬.
3.2. Effect of S. anacardium Linn. nut milk extract on 
glycogen metabolism
  The changes in the level of glycogen content and 
alterations in the activity of glycogen phosphorylase in liver 
of control and experimental group of rats have been shown 
in Table 2. The level of glycogen content in liver tissue was 
reduced significantly (P<0.05) in diabetic control group of 
rats. Treatment with the drug S. anacardium resulted in 
significant increase in glycogen content.
3.3. Effect of S. anacardium Linn. nut milk extract on 
glycolytic enzymes and gluconeogenic enzymes
  The alterations in the activities of glycolytic enzymes and 
gluconeogenic enzymes were depicted in Table 3 and 4, 
respectively. Significant decrease (P<0.05) in glycolytic 
enzymes and a significant increase (P<0.05) in the 
gluconeogenic enzymes were observed in diabetic rats when 
compared with control rats. Upon treatment with the drug S. 
anacardium and metformin the activities of these enzymes 
were restored. 
3.4. Effect of S. anacardium Linn. nut milk extract on Gsk -3
  Figure 1 shows the mRNA expression of GSK -3 in the 
liver of control and experimental group of animals. The 
expression of GSK -3 was increased in the diabetic group 
of rats. But upon treatment with the drug S. anacardium its 
expression was restored. 
Table 1
Effect of S. anacardium nut milk extract on fasting glucose, insulin, HOMA-IR and HOMA-毬 of control and experimental animals.
Groups Glucose Insulin HOMA-IR HOMA-毬
Group栺  103.00依4.20 23.46依0.95 4.52依0.32  461.69依32.45
Group栻      265.00依15.32 a   17.00依1.35 a  8.91依0.73a   347.12依24.67a
Group栿       125.00依11.46 ab   29.00依1.15ab   5.28依0.42ab     431.02依38.57 ab
Group桇       133.00依18.65 ab   18.00依1.65ab   6.73依0.45ab    130.80依11.57ab
Group桋 105.00依4.88 21.60依1.15 4.20依0.34 378.60依38.04
Values are expressed as mean 依SD for 6 animals. 
a: Group 栺 vs. other groups P<0.05, b: group栻 vs. 栿, 桇 and 桋P<0.05.
Table 2
Effect of S. anacardium nut milk extract on glycogen metabolism of control and experimental animals.
Groups Glycogen phosphorylase Glycogen synthase Glycogen
Group栺 11.56 依 1.04 45.62 依3.12 79.08 依 5.75
Group栻   25.88 依 2.19 a    25.32 依 1.80 a   40.19 依 3.56 a
Group栿    11.87 依 0.98 ab   40.00 依3.10ab    75.57 依 6.01 ab
Group桇    16.93 依 1.27 ab   35.00 依1.67ab    65.28 依 4.71 ab
Group桋 11.62 依 0.85  46.00 依1.25 79.12 依 6.24 
Units: Glycogen phosphorylase-毺mol of inorganic phosphorous liberated/hr/mg protein; Glycogen synthase 毺mol of uridine diphosphate 
liberated/hr/mg protein; Glycogen-mg glucose/g tissue.
Values are expressed as mean 依SD for 6 animals.  
a: Group 栺 vs. other groups P<0.05, b: group栻 vs. 栿, 桇 and 桋P<0.05.
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Figure  1. Effect of S. anacardium nut milk extract on gene expression 
of GSK-3 in liver control and experimental group of rats.
M: 100 bp marker; L1: Group 栺(Control); L2: Group栻(DC: 
Diabetic control); L3: Group 栿 (DC+SA: Diabetes induced and SA:
S. anacardium treated); L4: Group桋(Control and SA: S. anacardium 
alone).   
a: Group 栺 vs. other groups P<0.05, b: group栻 vs. 栿, P<0.05.
4. Discussion  
  Type 2 diabetes mellitus is the most common form of the 
metabolic disorder which is caused by impaired insulin 
secretion paralleled by a progressive decline in 毬 cell 
function and chronic insulin resistance[21]. Nowadays there 
has been a growing interest in herbal remedies that can 
be introduced into the general population with the least 
side effects and maximum preventive outcome[22]. Herbal 
medicines can only be effective as an alternative to oral 
hypoglycaemic agents, in type 2 diabetes where pancreatic 
islets are not totally destroyed. Hence, we used a type 2 
diabetic rat model to study the anti diabetic effect of the 
drug.
  Insulin resistance and 毬 cell dysfunction are the important 
characteristics of type 2 diabetes mellitus. Therefore, we 
studied the effect of Semecarpus anacardium on blood 
glucose and insulin levels and also performed HOMA-IR 
and HOMA-毬 to check the degree of insulin resistance 
and beta cell function. The drug S. anacardium effectively 
reduced the blood glucose levels thereby establishing its 
hypoglycaemic effect[23]. A significant decrease in HOMA-IR 
and an increase in both insulin concentration and HOMA-毬 
level by treatment with the drug S. anacardium suggests that 
improvement in the glucose homeostasis is plausibly due 
to an improvement in insulin action and 毬- cell function. 
Flavonoids present in the drug might have contributed to 
this effect. 
  The synthesis and degradation of glycogen in the liver 
and skeletal muscle tissues are the important mechanisms 
involved in the control of blood glucose homeostasis and 
alterations in glycogen metabolism have been observed 
in diabetic rats consistent with other studies[24]. The 
activities of the enzymes, glycogen synthase and glycogen 
phosphorylase were considerably altered in diabetic rats 
thereby indicating insulin resistance. Oral administration 
of S. anacardium to diabetic rats resulted in an increase in 
glycogen content in liver and also increased the activity of 
glycogen synthase enzyme while decreasing the activity of 
glycogen phosphorylase. There by indicating the possible 
effect of the drug on sensitizing these tissues for glucose 
uptake and storage. 
  In type 2 diabetes mellitus, hyperglycemia results from 
both lack of suppression of hepatic glucose production and 
also results from decreased glucose uptake by peripheral 
tissue skeletal muscle since it accounts for 80% of 
glucose disposal[25]. Hence enzymes that regulate glucose 
Table 3
Effect of S. anacardium nut milk extract on glycolytic enzymes in liver of control and experimental animals.
Groups Glycokinase Phosphogluco isomerase  isomerase Aldolase
Group栺 18.87 依 1.56 14.69 依 1.20 13.80 依 0.97 
Group栻  10.05 依 0.92a     8.21 依 0.64 a     6.56 依 0.42 a
Group栿    17.47 依 1.23 ab    12.56 依 1.04ab    11.43 依 0.81 ab
Group桇    15.61 依 1.09 ab    14.50 依 0.96ab    13.67 依 1.12 ab
Group桋 18.83 依 1.64    14.74 依 1.31 13.86 依 1.10 
Units: Hexokinase- nmol of glucose-6-phosphate liberated/min/mg protein, Phosphoglucoisomerase-nmol of fructose liberated/min/mg protein, 
Aldolase-nmol of glyceraldehyde liberated/min/mg protein.
Values are expressed as mean 依SD for 6 animals.  
a: Group 栺 vs. other groups P<0.05, b: group栻 vs. 栿, 桇 and 桋P<0.05.
Table 4
Effect of S. anacardium nut milk extract on gluconeogenic enzymes in liver of control and experimental animals.
Groups Glucose 6 phosphatase Fructose 1,6 bisphosphatase Glucose 6 phosphate dehydrogenase
Group栺 13.01 依 0.96   17.56 依 1.32     5.45 依 0.38 
Group栻    7.71 依 0.52a       8.89 依 0.69 a       2.77 依 0.16 a
Group栿     12.90 依  0.90 ab     14.71 依 1.14ab         5.26 依 0.31 ab
Group桇    11.64 依 1.01 ab     14.50 依 0.96ab         4.08 依 0.24 ab
Group桋 12.95 依 1.21   17.60 依 1.50      5.49 依 0.18 
Units: Glucose-6-phosphatase&Fructose1, 6-bisphosphatase-nmol of inorganic phosphorous liberated/min/mg protein, Glucose 6-phosphate 
dehydrogenase-Units/mg protein.
Values are expressed as mean 依SD for 6 animals.  
a: Group 栺 vs. other groups P<0.05, b: group栻 vs. 栿, 桇 and 桋P<0.05.
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metabolism are potential targets for controlling hepatic 
glucose balance and thereby blood glucose levels in type 2 
diabetes. A significant decrease in the activities of glycolytic 
enzymes hexokinase, phosphoglucoisomerase and aldolase 
were observed in diabetic rats consistent with that of other 
studies[26]. The restoration of the activities of the glycolytic 
enzymes by the drug might be due to the presence of 
flavonoids and polyphenolic compounds in the drug, since 
several researchers have shown that polyphenols have the 
capacity to modulate carbohydrate metabolizing enzymes in 
liver and skeletal muscle by improving pancreatic 毬 cell 
function as well as exerting insulinomimetic action[27].
  In type 2 diabetes, activation of gluconeogenic enzymes is 
due to the state of insulin resistance the predominant cause 
of the elevated EGP. The activities of glucose 6 phosphatase 
and fructose 1, 6 bisphosphatase were significantly altered 
in liver of diabetic rats when compared with normal control 
rats. This is mainly due to insulin resistance resulting in 
the activation of the gluconeogenic enzymes contributing to 
hepatic glucose production, since under normal conditions, 
insulin functions as a suppressor of gluconeogenic 
enzymes[28]. Treatment of diabetic rats with the drug S. 
anacardium and metformin resulted in a decrease in the 
activities of gluconeogenic enzymes. S. anacardium might 
have brought this effect by increasing the insulin levels.
  Decreased activity of glucose-6-phosphate dehydrogenase 
enzyme the rate-limiting step of the HMP shunt pathway 
was observed in type 2 diabetic rats in agreement with other 
studies[29-31]. The restoration in the activity of this enzyme 
upon treatment with the drug might be due to its anti oxidant 
effect and also its protective effect of the drug by increasing 
insulin levels. Diabetic rats treated with S.anacardium 
showed significantly increased liver glucose-6-phosphate 
dehydrogenase activity and this resulted in an increased 
production of the reducing agent, NAD, with concomitant 
decrease in oxidative stress. 
  Glycogen synthase kinase-3 (GSK-3) a serine/threonine 
kinase plays an important role in the regulation of glycogen 
synthesis and it suppresses the function of two key targets 
of insulin action namely, glycogen synthase and insulin 
receptor substrate-1and its activity is higher in diabetic 
tissues[32]. Oxidative stress is known to induce insulin 
resistance through reduced insulin-mediated suppression 
of the active form of GSK-3 in type 2 diabetic rats[33]. 
The inhibition of GSK-3 leads to an increase in glycogen 
synthesis, which promotes insulin sensitivity. Activation 
of GSK-3 leads to reduction in glycogen synthesis and 
decrease in insulin sensitivity. Hence, we studied the 
effect of the drug S. anacardium in modulating this insulin 
signalling molecule. Increased expression of GSK -3 seen 
in diabetic animals was decreased in S. anacardium treated 
animals. The decrease in the mRNA expression of GSK-3 in 
our study is correlated with an increase in glycogen content 
in both liver and skeletal muscle. This shows the activity 
of the drug in improving the insulin sensitivity. Flavonoids 
and plant derived products have been shown to inhibit the 
expression of GSK-3[34].
  In recent times, attention has been shifted to herbal drugs as 
potential agents for treatment of type 2 diabetes. Identifying 
targets of action of these preparations is an essential aspect 
of therapeutic drug development in combating metabolic 
alterations and molecular lesions characteristic of insulin 
resistance and type 2 diabetes. The drug effectively 
restored the glycolytic and suppressed the gluconeogenic 
pathway thereby improving or restoring the carbohydrate 
metabolism. The present study effectively shows that high 
fat diet STZ induced type 2 diabetes is characterized by 
disordered carbohydrate metabolism and also impaired 
insulin signalling. S. anacardium is adequately competent 
to counteract these effects of diabetic manifestations. This 
is mainly due to the presence of flavonoids in the drug, 
since they are known to have beneficial effect on the 
carbohydrate metabolism by up regulating the expression 
of glycolytic enzymes and decreasing the expression of 
gluconeogenic enzymes. However, the future prospective use of
S. anacardium in the treatment of type 2 diabetes warrants 
exhaustive experimental and clinical studies to determine 
the exact nature of active principle and its mechanism of 
action for development as an alternative therapeutic agent 
against type 2 diabetes mellitus s. 
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